FBRX Forte Biosciences, Inc.
76.99USD0.00%Mkt Cap: 1.63B $P/E: —41d ago
Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases. The company offers products, such as its lead product candidate FB102, a propriet…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap1.63B USD
Enterprise Value1.74B USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-69.38M USD
Revenue/Share—
Last Price76.99 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees23
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS34962G1094
Valuation
P/E (Trailing)—
P/E (Forward)-18.89
PEG—
EV/EBITDA-18.38
EV/Revenue—
P/S—
P/B10.24
EPS (TTM)-4.57
EPS (Forward)-4.08
52W Range
10.11100% of range77.19
52W High77.19 USD
52W Low10.11 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-113.75%
ROA-83.81%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-50.88M USD
CapEx (TTM)116.00K USD
FCF Margin—
FCF Yield-2.53%
Net Debt-198.46M USD
Net Debt/EBITDA2.10
Balance Sheet
Debt/Equity—
Current Ratio10.01
Quick Ratio9.82
Book Value/Sh7.52 USD
Cash/Share7.88 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateAug 28, 2024
Analyst Consensus
Rating2.5 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)73.00 USD
Upside (mean)-5.2%
Target Range61.00 USD – 77.00 USD
61.00-5.2% to mean77.00
# Analysts4
Ownership
Shares Out.21.23M
Float18.67M
Insiders2.06%
Institutions96.65%
Short Interest
Short Ratio0.8d
Short % Float7.74%
Short % Out.7.69%
Shares Short1.63M
Short (prev mo.)2.06M
Technical
SMA 5055.18 (+39.5%)
SMA 20033.25 (+131.5%)
Beta2.65
S&P 52W Chg16.45%
Avg Vol (30d)1.96M
Avg Vol (10d)1.69M
Technical Indicators
RSI (14)85.1
MACD6.9100
MACD Signal8.6934
MACD Hist.-1.7834
BB Upper77.10 USD
BB Middle76.80 USD
BB Lower76.50 USD
BB Width0.79%
ATR (14)1.423 USD
Vol Ratio (20d)0.00x